PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (16 December 2020)
Question Asked
Asked by:
Esther McVey (Conservative)
Answer
The Pfizer/BioNTech vaccine has met the Medicines and Healthcare products Regulatory Agency’s robust standards of safety, quality, and effectiveness, and the safety data from the trials has set out how the COVID-19 vaccine works in different types of people. A robust and proactive safety monitoring strategy for COVID-19 vaccines is in place, which allows for rapid, real-time safety monitoring at population level.
Answered by:
Nadhim Zahawi (Conservative)
11 January 2021
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.